[Reassessing androgen deprivation therapy (ADT) in older men with advanced prostate cancer: when to use, when to discontinue, and role as monotherapy?] [0.03%]
老年晚期前列腺癌患者的雄激素剥夺治疗（ADT）的再评估：何时使用，何时停止以及单药治疗的作用？
Martina Heller,Stefanie Zschäbitz
Martina Heller
Background: Androgen deprivation therapy (ADT) remains the standard of care for the treatment of advanced and metastatic prostate cancer (PC). However, in older patients, the choice of treatment must be made carefully, as...
[Oligometastatic hormone-sensitive prostate cancer: when can less be more?] [0.03%]
[寡转移性雄激素敏感前列腺癌：此时少即是多吗？]
Richard Cathomas
Richard Cathomas
With the use of modern imaging technology such as prostate-specific membrane antigen positron emission tomography-computed tomography (PSMA PET-CT), compared to conventional imaging with CT and bone scan, in the primary staging of localized...
Fabian P Stangl,Jennifer Kranz
Fabian P Stangl
Multidrug-resistant pathogens are the result of cumulative risk constellations and inappropriate antibiotic use. Multidrug-resistant Gram-negative bacteria are of particular relevance, especially in patients with prior antibiotic therapy, r...
[Non-muscle-invasive urothelial carcinoma of the bladder: time for a de-escalation of treatment and aftercare] [0.03%]
[膀胱非肌层浸润性尿路上皮癌：治疗和随访该减速了]
Axel Heidenreich
Axel Heidenreich
The aim of this review is to provide information on evidence-based therapy and aftercare strategies of low-risk bladder cancer. For low-grade non-muscle-invasive urothelial carcinoma of the bladder (LG-NMIB), active surveillance (AS) is rec...
[Artificial intelligence as decision support tool in urological oncology: current evidence and challenges] [0.03%]
[人工智能在泌尿系统肿瘤学中的决策支持作用：现状、证据及挑战]
Lisa Maria Jost,Gregor Duwe,Verena Kauth et al.
Lisa Maria Jost et al.
Background: The rising incidence of cancer, increasing life expectancy and complex personalized treatment concepts pose considerable challenges for the healthcare system. Artificial intelligence (AI)-in particular machine...
[Genetic testing in prostate cancer-what the new S3 guideline means for urological practice] [0.03%]
前列腺癌的基因检测——泌尿外科实践中的新S3指南意味着什么？
Alexander Volk,Bernd Auber,Lars Budäus
Alexander Volk
[Reducing overdiagnosis-how to do I correctly assess the indication for prostate biopsy?] [0.03%]
[减少过度诊断-如何正确评估前列腺活检指征?]
Felix Seelemeyer,Rouvier Al-Monajjed,Muammar Dib et al.
Felix Seelemeyer et al.
The indication for prostate biopsy represents the key interface between prostate-specific antigen (PSA)-based early detection and primary diagnostic evaluation in patients with suspected prostate cancer. The aim is to reduce overdiagnosis w...
[Uncomplicated urinary tract infections: antibiotic-sparing approaches] [0.03%]
[无复杂性的泌尿系感染：减少使用抗生素的方法]
Sebastian Graf
Sebastian Graf
Background: With increasing antimicrobial resistance, the attractiveness of antibiotic-sparing approaches in urinary tract infections increases. Objective...